glp-1 agonists marketing strategies 2025 Market Size, Share, Growth Insights 2032 GLP-1 Market Size, Share |
Description
For example, Meissner et al133 conducted a randomized controlled trial evaluating lixisenatide in patients with early stage PD receiving standard treatment
Exenatide efficacy and safety: a systematic review
doi: 10.1016/S2213-8587(22)00349-7 [DOI] [PubMed] [Google Scholar] 217.Scheen AJ, Paquot N, Lefbvre PJ
p = 0.012)
However, GLP-1 is only able to create these effects for a short time-span due to the fact that it disappears over time
L., Zhou C., Li X
